Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -59.90% is 14% above its 5-year average of -69.69%, near the high end of its 5-year range (-281.12%–-22.89%).
As of the fiscal period ended Tuesday, June 30, 2026. 32.16% above its 12-month average of -88.30%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -59.90%.
RETURN ON INVESTED CAPITAL (ROIC)
-59.90%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-88.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-137.90%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-69.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+32.16%
CURRENT VS 3Y AVG
+56.56%
CURRENT VS 5Y AVG
+14.04%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 652 covered companies
CURRENT VS SECTOR MEDIAN
-78.21%
vs the sector median at left
Invivyd, Inc.
Market Cap
$248.32M
Return on Invested Capital (ROIC)
-59.90%
TTM Avg
-88.30%
3Y Avg
-137.90%
5Y Avg
-69.69%
Market Cap
$245.38M
Return on Invested Capital (ROIC)
-701.55%
TTM Avg
-3723.51%
3Y Avg
-1911.77%
5Y Avg
-1278.48%
Market Cap
$243.48M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-8.11%
3Y Avg
-7.60%
5Y Avg
-6.24%
Market Cap
$242.34M
Return on Invested Capital (ROIC)
-7.08%
TTM Avg
-12.89%
3Y Avg
-21.42%
5Y Avg
-39.95%
Market Cap
$248.50M
Return on Invested Capital (ROIC)
-40.52%
TTM Avg
-35.57%
3Y Avg
-28.84%
5Y Avg
-24.57%
Market Cap
$243.67M
Return on Invested Capital (ROIC)
-1718.59%
TTM Avg
-749.70%
3Y Avg
-566.74%
5Y Avg
-409.31%
Market Cap
$242.30M
Return on Invested Capital (ROIC)
-25.38%
TTM Avg
-99.58%
3Y Avg
-69.59%
5Y Avg
-61.10%
Market Cap
$256.22M
Return on Invested Capital (ROIC)
-43.69%
TTM Avg
-34.60%
3Y Avg
-35.16%
5Y Avg
-35.84%
Market Cap
$240.31M
Return on Invested Capital (ROIC)
-69.76%
TTM Avg
-64.00%
3Y Avg
-45.05%
5Y Avg
-31.07%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Invivyd, Inc. (IVVD) | $248.32M | -59.90% | -88.30% | -137.90% | -69.69% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $245.38M | -701.55% | -3723.51% | -1911.77% | -1278.48% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.48M | N/A | -8.11% | -7.60% | -6.24% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $242.34M | -7.08% | -12.89% | -21.42% | -39.95% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $248.50M | -40.52% | -35.57% | -28.84% | -24.57% |
| Galectin Therapeutics Inc. (GALT)vs › | $243.67M | -1718.59% | -749.70% | -566.74% | -409.31% |
| InflaRx N.V. (IFRX)vs › | $242.30M | -25.38% | -99.58% | -69.59% | -61.10% |
| Century Therapeutics, Inc. (IPSC)vs › | $256.22M | -43.69% | -34.60% | -35.16% | -35.84% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.31M | -69.76% | -64.00% | -45.05% | -31.07% |
| Anika Therapeutics, Inc. (ANIK)vs › | $257.42M | -3.17% | -4.70% | -2.14% | -2.73% |
ROIC
-59.9%
ROE
-59.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -59.90% |
| 2026-03-31 | -38.92% |
| 2025-12-31 | -22.89% |
| 2025-09-30 | -65.74% |
| 2025-06-30 | -254.04% |
| 2025-03-31 | -272.78% |
| 2024-12-31 | -261.89% |
| 2024-09-30 | -281.12% |
| 2024-06-30 | -152.98% |
| 2024-03-31 | -122.70% |
| 2023-12-31 | -118.93% |
| 2023-09-30 | -74.24% |
| 2023-06-30 | -66.63% |
| 2023-03-31 | -56.46% |
| 2022-12-31 | -69.26% |
| 2022-09-30 | -74.66% |
| 2022-06-30 | -71.03% |
| 2022-03-31 | -62.71% |
| 2021-12-31 | -40.66% |
| 2021-09-30 | -32.80% |
| 2021-06-30 | -54.23% |
| 2021-03-31 | -227.65% |
